Skip to content

13F-HR/A filed by Avidity Partners Management LP

Avidity Partners Management LP filed this 13F-HR/A for the quarter ended 2020-03-31, filed 2020-06-17, with 52 holding rows worth $723,593,000.

Accession
0000919574-20-004168
Filed
2020-06-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2020

A holdings report, amendment of type new holdings, 52 entries on the cover page, a total value of $723,593,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $723,593,000 with VALUE read as thousands by filing date, 13F file number 028-20028. Its rows are added to the quarter's base report (NEW HOLDINGS). The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SEATTLE GENETICS INC812578102COM580,000$66,920,000thousands by filing date
Merck & Co.,Inc.58933Y105COM492,000$37,854,000thousands by filing date
AbbVie,Inc.00287Y109COM477,000$36,343,000thousands by filing date
MCKESSON CORP COM58155Q103Stock243,000$32,868,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM302,000$25,519,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock50,000$24,415,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM505,000$24,210,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM295,000$22,677,000thousands by filing date
CATALENT INC USD 0.01148806102COM411,000$21,351,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM780,000$21,216,000thousands by filing date
BIOGEN INC COM09062X103Stock62,000$19,616,000thousands by filing date
EXELIXIS INC COM30161Q104Stock1,086,000$18,701,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM540,000$18,376,000thousands by filing date
ALECTOR INC014442107COMMON STOCK714,000$17,229,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock1,182,000$17,151,000thousands by filing date
CVS Health Corporation126650100COM277,000$16,434,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM357,000$15,083,000thousands by filing date
Gilead Sciences,Inc.375558103COM200,000$14,952,000thousands by filing date
ACCELERON PHARMA INC00434H108COM166,000$14,918,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM160,000$14,366,000thousands by filing date
SEATTLE GENETICS INC812578102COM117,700$13,581,000thousands by filing datecall
DYNAVAX TECHNOLOGIES CORP268158201COM NEW3,824,000$13,499,000thousands by filing date
KADMON HLDGS INC48283N106COM2,828,000$11,849,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock197,000$11,590,000thousands by filing date
Cigna Corporation125523100COM65,000$11,517,000thousands by filing date
UNIQURE NVN90064101SHS237,000$11,246,000thousands by filing date
MODERNA INC60770K107COM365,000$10,932,000thousands by filing date
HUMANA INC COM444859102Stock33,000$10,363,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS333,000$9,863,000thousands by filing date
CHEMOCENTRYX INC16383L106COM236,000$9,482,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM98,000$8,482,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM34,000$8,090,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM80,000$7,826,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW102,000$7,417,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK735,000$7,416,000thousands by filing date
VERASTEM INC92337C104COM2,790,698$7,367,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM57,000$7,194,000thousands by filing date
ALLERGAN PLCG0177J108SHS40,000$7,084,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM507,000$6,845,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR60,000$6,757,000thousands by filing date
IMMUNOMEDICS INC452907108COM493,000$6,646,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW1,624,800$6,499,000thousands by filing datecall
ESPERION THERAPEUTICS INC NEW COM29664W105Stock205,000$6,464,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM382,000$6,196,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock990,000$5,960,000thousands by filing datecall
AIMMUNE THERAPEUTICS INC.00900T107Common Stock408,000$5,883,000thousands by filing date
ANIKA THERAPEUTICS INC035255108COM168,000$4,857,000thousands by filing date
BIOXCEL THERAPEUTICS INC09075P105COM211,000$4,716,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO382,000$3,033,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock444,200$2,674,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328700COM4,310,000$1,788,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM17,000$278,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-20-003442 base2020-05-15acceptance time not in the bulk data set
13F-HR/A 0000919574-20-004168this filing2020-06-17acceptance time not in the bulk data set